Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
HistoSonics considering a sale to major medtechs: report
HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according to the Financial Times.
Conor Hale
May 2, 2025 11:30am
Investor pressures Acelyrin to exit Alumis merger and liquidate
Apr 30, 2025 10:30am
Novartis pays $800M to buy Regulus for phase 3-ready kidney drug
Apr 30, 2025 9:30am
M&A remains ‘top priority’ for pharmas in face of tariff threat
Apr 25, 2025 10:41am
Tariffs make M&A decisions 'more difficult,' says Roche CEO
Apr 24, 2025 4:40am
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Apr 23, 2025 6:20am
